SBIR / STTR #PA-27-100

HHS SBIR/STTR Research and Development Grant for Small Businesses (NIH, CDC, FDA)

The Department of Health and Human Services (HHS), including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA), is inviting U.S. small businesses to apply for SBIR and STTR research and development grants. - Opportunity is open to all eligible U.S. small businesses; no specific OEMs or vendors are named - Supports research and development (R&D) projects aimed at developing commercial products or technologies aligned with the missions of NIH, CDC, or FDA - Covers SBIR Phase I, Phase II, Direct to Phase II (NIH only), and Fast-Track (NIH only) applications - Projects must be primarily conducted by the small business, with limited involvement from research partners or consultants - No specific products, part numbers, or quantities are listed, as this is a broad R&D funding opportunity - Proposals not aligned with the solicitation scope, including certain clinical trials, will not be reviewed - Applicants are encouraged to align proposals with agency mission statements and strategic priorities

Description

This solicitation supports small businesses in conducting research and development to develop commercial products aligned with the missions of NIH, CDC, or FDA. The project should primarily be conducted by the small business with limited involvement from partners or consultants. The program includes Phase I to establish technical merit and feasibility, Phase II to advance commercialization, and Post-Phase II for full commercialization using non-SBIR/STTR funds. Special application types include Fast-Track and Direct to Phase II for eligible projects. Applications not aligned with the scope or proposing non-qualifying clinical trials will not be reviewed.

View original listing